RCEL vs SSII: stock comparison and AI forecast
Avita Medical, Inc. (RCEL) and Ss Innovations International, Inc. (SSII) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
RCEL Avita Medical, Inc.
- Price
- $15.41 +260.0% · 6M
- Market Cap
- $477M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
SSII Ss Innovations International, Inc.
- Price
- $2.31 -43.0% · 6M
- Market Cap
- $463M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- RCEL and SSII have similar market capitalizations ($477M and $463M).
- Over the last six months RCEL returned +260.0% and SSII -43.0%.
- Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | RCEL | SSII |
|---|---|---|
| Market Cap | $477M | $463M |
| P/B Ratio | – | 8.67x |
| EPS | $-1.61 | $-0.03 |
| Book Value/Share | – | $0.27 |
| Revenue/Share | $2.45 | – |
| FCF/Share | $-0.80 | – |
Profitability & Margins
| Metric | RCEL | SSII |
|---|---|---|
| ROA | -90.2% | – |
| ROIC | 168.2% | -11.8% |
| Gross Margin | 81.6% | 48.3% |
| Operating Margin | -46.6% | -15.1% |
| Net Margin | -57.0% | – |
| EBT Margin | -56.9% | -14.5% |
| Tax Rate | -0.1% | -38.8% |
Financial Health
| Metric | RCEL | SSII |
|---|---|---|
| Current Ratio | 0.41x | 2.24x |
| Quick Ratio | 0.34x | 1.66x |
| D/E Ratio | – | 0.82x |
| Financial Leverage | – | 1.82x |
| Interest Coverage | -4.7x | -54.9x |
| Working Capital | -$40M | $40M |
Cash Flow
| Metric | RCEL | SSII |
|---|---|---|
| Operating Cash Flow | -$24M | -$24M |
| Free Cash Flow | -$25M | – |
| Capital Spending | -$390K | – |
| FCF/Sales | -32.5% | – |
| CapEx/Sales | 0.5% | – |
Operational Efficiency
| Metric | RCEL | SSII |
|---|---|---|
| Asset Turnover | 1.58x | – |
| Receivables Turnover | 7.7x | – |
| Inventory Turnover | 2.6x | 1.0x |
| Fixed Assets Turnover | 9.8x | – |
| Days Sales Outstanding | 48 days | – |
| Days Inventory | 138 days | 350 days |
| Payables Period | – | 100 days |
Income Statement
| Metric | RCEL | SSII |
|---|---|---|
| Total Revenue | $76M | – |
| Operating Income | -$35M | -$8M |
| Net Income | -$43M | – |
| R&D Expense | $20M | $5M |
| SG&A Expense | $90M | $17M |
| Cost of Goods Sold | $14M | $19M |
Dividend & Shareholder Information
| Metric | RCEL | SSII |
|---|---|---|
| Shares Outstanding | 31M | 200M |
RCEL vs SSII: stock comparison and AI forecast
Which is bigger, RCEL or SSII?
RCEL and SSII have similar market capitalizations ($477M and $463M).
Which stock performed better over the last six months, RCEL or SSII?
Over the last six months RCEL returned +260.0% and SSII -43.0%.
Which one does Intratio's AI model rank higher, RCEL or SSII?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.